Intensive Treatment for Intermediate-Risk Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies
ID Number 80-0066-00067Principal Investigator(s)
Department(s) or Division(s)
Hematology and Oncology
The purpose of this study is:
1) To find out the effectiveness and side effects of the high dose combination chemotherapy treatment for all subjects on this study (A “subject” is a person taking part in the study.)
2) To find out the effectiveness and side effects of higher dose vincristine compared to standard dose vincristine.
You/your child may qualify for participation in this study because you/your child have been treated in the past for a cancer of the blood cells called acute lymphoblastic leukemia (ALL).
Recruiting Patients: Yes